v3.26.1
Intangible Assets (Tables)
12 Months Ended
Dec. 31, 2025
Intangible assets other than goodwill [abstract]  
Summary of Reconciliation of Changes in Intangible Assets and Goodwill
Rights to
Produce and
Distribute Coca-Cola Trademark Products
GoodwillTrademark RightsOther
Indefinite Lived Intangible
Assets
Total Unamortized Intangible
Assets
Technology Costs and Management Systems
Customer Relationships (1)
Alcohol
Licenses
OtherTotal Amortized Intangible
Assets
Total Intangible
Assets
Cost as of January 1, 2023Ps.75,756 Ps.85,704 Ps.9,044 Ps.1,265 Ps.171,769 Ps.10,905 Ps.13,488 Ps.1,977 Ps.5,531 Ps.31,901 Ps.203,670 
Additions — — — 1,966 — 261 1,174 3,401 3,405 
Acquisitions from business combinations (see Note 4) — 3,918 26 — 3,944 145 188 — 25 358 4,302 
Changes in fair value of past acquisitions— (12,273)7,683 — (4,590)— 5,162 — (117)5,045 455 
Business disposals(12)(25,036)(3,009)(56)(28,113)(482)(17,788)— (29)(18,299)(46,412)
Transfer of completed development systems (224)— — 227 292 — — (295)(3)— 
Disposals — (2)— (2)(4)(197)— (161)(235)(593)(597)
Effect of movements in exchange rates (1,568)(3,744)(810)45 (6,077)(424)(814)— (683)(1,921)(7,998)
Changes in value on the recognition of inflation effects— — — — — — — — 70 70 70 
Impairment— (4,995)— — (4,995)— — — — — (4,995)
Business combinations from disposals— 1,950 — — 1,950 — — — — — 1,950 
Cost as of December 31, 2023Ps.73,952 Ps.45,522 Ps.12,934 Ps.1,483 Ps.133,891 Ps.12,205 Ps.236 Ps.2,077 Ps.5,441 Ps.19,959 Ps.153,850 
(1)Includes customer relationships related to the acquisitions through Envoy Solutions disclosed in Note 4.
Rights to
Produce and
Distribute Coca-Cola Trademark
Products
GoodwillTrademark RightsOther
Indefinite Lived Intangible
Assets
Total Unamortized Intangible
Assets
Technology Costs and Management Systems
Customer Relationships (1)
Alcohol
Licenses
OtherTotal Amortized Intangible
Assets
Total Intangible
Assets
Cost as of January 1, 2024Ps.73,952Ps.45,522Ps.12,934Ps.1,483Ps.133,891Ps.12,205Ps.236Ps.2,077Ps.5,441Ps.19,959Ps.153,850
Additions 461955561,7743881,2103,0753,631
Acquisitions from business combinations (see Note 4) 2,8092,8091,2161,2164,025
Changes in fair value of past acquisitions(3)3
Transfer of completed development systems670(670)
Disposals (50)(50)(76)(31)(107)(157)
Effect of movements in exchange rates 657(371)289225972,434466145(867)2,1782,775
Changes in value on the recognition of inflation effects256(123)133133
Impairment (1,797)(1,004)(2,801)(2,801)
Cost as of December 31, 2024 Ps.74,609Ps.46,624Ps.12,219Ps.1,550Ps.135,002Ps.17,263Ps.702Ps.2,310Ps.6,179Ps.26,454Ps.161,456

Rights to
Produce and
Distribute Coca-Cola Trademark
Products
GoodwillTrademark RightsOther
Indefinite Lived Intangible
Assets
Total Unamortized Intangible
Assets
Technology Costs and Management SystemsCustomer RelationshipsAlcohol
Licenses
OtherTotal Amortized Intangible
Assets
Total Intangible
Assets
Cost as of January 1, 2025Ps.74,609Ps.46,624Ps.12,219Ps.1,550Ps.135,002Ps.17,263Ps.702Ps.2,310Ps.6,179Ps.26,454Ps.161,456
Additions 311146082272,6963,5313,545
Changes in fair value of past acquisitions(627)(627)(10)(10)(637)
Reclassifications from assets held for sale240240240
Internal development505050
Transfer of completed development systems 45(202)(157)(157)
Disposals (8)(28)(36)(149)(4)(4)(157)(193)
Effect of movements in exchange rates (402)105(508)7(798)(485)(3)(406)(894)(1,692)
Changes in value on the recognition of inflation effects545454
Reclassifications654(113)108(541)108108
Cost as of December 31, 2025Ps.74,207Ps.46,102Ps.11,706Ps.1,540Ps.133,555Ps.18,040Ps.582Ps.2,645Ps.7,952Ps.29,219Ps.162,774
    
Amortization and Impairment LossesRights to
Produce and
Distribute Coca-Cola Trademark
Products
GoodwillTrademark RightsOther
Indefinite Lived Intangible
Assets
Total Unamortized Intangible
Assets
Technology Costs and Management SystemsCustomer RelationshipsAlcohol
Licenses
OtherTotal Amortized Intangible
Assets
Total Intangible
Assets
Amortization as of January 1 2023Ps.Ps.Ps.Ps.Ps.Ps.(7,021)Ps.(3,152)Ps.(939)Ps.(1,786)Ps.(12,898)Ps.(12,898)
Amortization expense (1,519)(1,113)(116)(547)(3,295)(3,295)
Disposals161209370370
Business disposals2764,010514,3374,337
Impairment(36)(36)(36)
Effect of movements in exchange rates 57818815187968968
Changes in value on the recognition of inflation effects(78)(78)(78)
Amortization as of December 31 2023 Ps.Ps.Ps.(36)Ps.Ps.(36)Ps.(7,603)Ps.(67)Ps.(1,040)Ps.(1,886)Ps.(10,596)Ps.(10,632)
Amortization as of January 1 2024 Ps.Ps.Ps.(36)Ps.Ps.(36)Ps.(7,603)Ps.(67)Ps.(1,040)Ps.(1,886)Ps.(10,596)Ps.(10,632)
Amortization expense (1,895)(17)(226)(479)(2,617)(2,617)
Disposals 562728585
Business disposals
Impairment
Effect of movements in exchange rates (745)(745)(648)(413)126(147)(1,082)(1,827)
Changes in value on the recognition of inflation effects(129)(129)(129)
Amortization as of December 31 2024 Ps.(745)Ps.Ps.(36)Ps.Ps.(781)Ps.(10,219)Ps.(470)Ps.(1,140)Ps.(2,510)Ps.(14,339)Ps.(15,120)
Amortization as of January 1 2025 Ps.(745)Ps.Ps.(36)Ps.Ps.(781)Ps.(10,219)Ps.(470)Ps.(1,140)Ps.(2,510)Ps.(14,339)Ps.(15,120)
Amortization expense (1,058)53(1)(1,561)(2,567)(2,567)
Disposals 71459134134
Business disposals(275)(275)(275)
Impairment6288
Effect of movements in exchange rates 449(16)276709709
Changes in value on the recognition of inflation effects (49)(49)(49)
Reclassifications(361)204(108)157(108)(108)
Amortization as of December 31 2025 Ps.(745)Ps.Ps.(36)Ps.Ps.(781)Ps.(11,161)Ps.(225)Ps.(1,249)Ps.(3,852)Ps.(16,487)Ps.(17,268)

Carrying AmountRights to
Produce and
Distribute Coca-Cola Trademark
Products
GoodwillTrademark RightsOther
Indefinite Lived Intangible
Assets
Total Unamortized Intangible
Assets
Technology Costs and Management SystemsCustomer RelationshipsAlcohol
Licenses
OtherTotal Amortized Intangible
Assets
Total Intangible
Assets
As of December 31 2023Ps.73,952Ps.45,522Ps.12,898Ps.1,483Ps.133,855Ps.4,602Ps.169Ps.1,037Ps.3,555Ps.9,363Ps.143,218
As of December 31 2024 Ps.73,864Ps.46,624Ps.12,183Ps.1,550Ps.134,221Ps.7,044Ps.232Ps.1,170Ps.3,669Ps.12,115Ps.146,336
As of December 31 2025 Ps.73,462Ps.46,102Ps.11,670Ps.1,540Ps.132,774Ps.6,879Ps.357Ps.1,396Ps.4,100Ps.12,732Ps.145,506
Summary of Allocation of Amortization Expenses
For the years ended December 31, 2025, 2024 and 2023, allocation for amortization expense is as follows:
    202520242023
 
Cost of goods sold Ps.175 Ps.49 Ps.1,229 
Administrative expenses 1,067 649 1,257 
Selling expenses 1,325 1,919 809 
 Ps.2,567 Ps.2,617 Ps.3,295 
Summary of Average Remaining Period for Company's Intangible Assets Subject to Amortization
The average remaining period for the Company’s intangible assets that are subject to amortization is as follows:
 Years
Technology Costs and Management Systems 
3 - 11
Customer Relationships
10 - 12
Alcohol Licenses 12
Summary of Disclosure of Aggregate Carrying Amounts of Goodwill and Distribution Rights Allocated to Each CGU
The aggregate carrying amounts of goodwill, distribution rights and other indefinite lived intangible assets allocated to each CGU are as follows:
December 31, 2025December 31, 2024
MexicoPs.56,971Ps.57,689
Guatemala1,6081,695
Nicaragua371404
Costa Rica1,5801,439
Panama1,0861,170
Colombia4,2273,638
Brazil27,99628,199
Argentina422512
Uruguay2,3932,452
TotalPs.96,654Ps.97,198
Summary of Details of Key Assumptions by CGU for Impairment Test
The key assumptions by CGU for impairment testing as of December 31, 2025 were as follows:
Pre-tax WACCPost-tax WACCExpected Annual Long-Term InflationExpected
Volume Growth Rates
CGU2026‑20302026‑2030
Mexico 8.8%6.2%3.9%5.0%
Brazil 11.4%7.2%3.9%3.3%
Colombia 10.5%7.9%3.4%3.5%
Argentina 16.8%11.8%10.1%5.2%
Guatemala 8.8%6.8%3.8%7.3%
Costa Rica 10.8%7.9%2.3%6.1%
Nicaragua 21.6%14.1%3.3%6.2%
Panama 11.3%8.6%1.0%5.6%
Uruguay 9.0%6.8%4.5%4.5%

The key assumptions by CGU for impairment testing as of December 31, 2024 were as follows:
Pre-tax WACCPost-tax WACCExpected Annual
Long-Term Inflation
Expected
Volume Growth Rates
CGU2025‑20292025‑2029 
Mexico 9.0%6.3%4.1%5.4%
Brazil 10.9%6.8%3.6%4.1%
Colombia 12.0%7.9%3.1%6.6%
Argentina 16.0%12.0%35.1%4.5%
Guatemala 9.5%7.2%4.0%11.9%
Costa Rica 12.0%8.5%2.8%6.6%
Nicaragua 23.0%13.1%3.5%6.5%
Panama11.7%9.1%1.8%6.3%
Uruguay 9.5%7.1%5.1%4.2%
The key assumptions by the significant CGU (Chile) in the Health Division (Mexico, Colombia and Ecuador are insignificant) for impairment test as of December 31, 2025 was as follows:
CGUPre-tax WACCPost-tax WACCExpected Annual
Long-Term 
Inflation
2026‑2030
Expected Sales Growth Rate
Chile 8.2%7.2%3.2%3.0%

The key assumptions by the significant CGU in the Health Division for impairment test as of December 31, 2024 was as follows:
CGUPre-tax WACCPost-tax WACCExpected Annual
Long-Term 
Inflation
2025‑2029
Expected Sales Growth Rates 2025‑2029
Chile6.8 %5.9 %3.1 %1.9 %
The key assumptions by CGU for impairment test as of December 31, 2025 were as follows:

CGUPre-tax WACCPost-tax WACCExpected Annual
Long-Term 
Inflation
2026‑2030
Expected Sales Growth Rates
Valora 5.4%5.0%0.9%5.7%
The key assumptions by CGU for impairment test as of December 31, 2024 was as follows:
CGUPre-tax WACCPost-tax WACCExpected Annual Long-Term Inflation 2025‑2029Expected Sales Growth Rates 2025‑2029
Valora 5.7%5.3%1.0%4.5%
Summary of Disclosure of Detailed Information About Sensitivity to Changes in Assumptions
                    
CGUChange in post-tax WACC
Change in Expected Volume Growth CAGR (1)
Effect on Valuation
Mexico 
+0.6
p.p.-1.0%Passes by 3.7x
Brazil 
+0.9
p.p.-1.0%Passes by 1.8x
Colombia 
+1.2
p.p.-1.0%Passes by 3.2x
Argentina 
+2.3
p.p.-1.0%Passes by 3.7x
Guatemala 
+0.7
p.p.-1.0%Passes by 5.7x
Costa Rica 
+0.7
p.p.-1.0%Passes by 4.6x
Nicaragua 
+3.4
p.p.-1.0%Passes by 1.4x
Panama 
+0.9
p.p.-1.0%Passes by 2.1x
Uruguay 
+0.2
p.p.-1.0%Passes by 3.4x
(1)Compound Annual Growth Rate (“CAGR”).
The sensitivity test by the significant CGU in the Health Division as of December 31, 2025 was as follows:
CGUChange in WACCChange in Expected Sales Growth Rates CAGREffect on Valuation
Chile 0.2p.p.(0.5)%Passes by 0.4x
On December 31, 2025, the Company performed an additional impairment sensitivity calculation, taking into account an effect of 50 basis points in the sale’s compound annual growth rate (“CAGR”), concluding that no impairment would be recognized.

CGUChange in Expected Sales Growth CAGREffect on Valuation
Valora (0.5)%Passes by -0.12x